Alzheimer's disease,the primary cause of dementia,is characterized by neuropathologies,such as amyloid plaques,synaptic and neuronal degeneration,and neurofibrillary tangles.Although amyloid plaques are the primar...Alzheimer's disease,the primary cause of dementia,is characterized by neuropathologies,such as amyloid plaques,synaptic and neuronal degeneration,and neurofibrillary tangles.Although amyloid plaques are the primary characteristic of Alzheimer's disease in the central nervous system and peripheral organs,targeting amyloid-beta clearance in the central nervous system has shown limited clinical efficacy in Alzheimer's disease treatment.Metabolic abnormalities are commonly observed in patients with Alzheimer's disease.The liver is the primary peripheral organ involved in amyloid-beta metabolism,playing a crucial role in the pathophysiology of Alzheimer's disease.Notably,impaired cholesterol metabolism in the liver may exacerbate the development of Alzheimer's disease.In this review,we explore the underlying causes of Alzheimer's disease and elucidate the role of the liver in amyloid-beta clearance and cholesterol metabolism.Furthermore,we propose that restoring normal cholesterol metabolism in the liver could represent a promising therapeutic strategy for addressing Alzheimer's disease.展开更多
To the Editor:Osteoarthritis(OA)is one of the most common age-related diseases and is characterized by synovial inflammation and progressive degradation of cartilage.It was reported that one-third of 65-year-olds and ...To the Editor:Osteoarthritis(OA)is one of the most common age-related diseases and is characterized by synovial inflammation and progressive degradation of cartilage.It was reported that one-third of 65-year-olds and 303 million people globally were affected by OA in 2017.[1,2]Although there is extensive research published on OA,its pathogenesis remains unclear and controversial.Cartilage degeneration is considered a key pathological factor that leads to disease progression.展开更多
基金financially supported by the Science and Technology Innovation Program of Hunan Province,No.2022RC1220(to WP)China Postdoctoral Science Foundation,No.2022M711733(to ZZ)+2 种基金the National Natural Science Foundation of China,No.82160920(to ZZ)Hebei Postdoctoral Scientific Research Project,No.B2022003040(to ZZ)Hunan Flagship Department of Integrated Traditional Chinese and Western Medicine(to WP)。
文摘Alzheimer's disease,the primary cause of dementia,is characterized by neuropathologies,such as amyloid plaques,synaptic and neuronal degeneration,and neurofibrillary tangles.Although amyloid plaques are the primary characteristic of Alzheimer's disease in the central nervous system and peripheral organs,targeting amyloid-beta clearance in the central nervous system has shown limited clinical efficacy in Alzheimer's disease treatment.Metabolic abnormalities are commonly observed in patients with Alzheimer's disease.The liver is the primary peripheral organ involved in amyloid-beta metabolism,playing a crucial role in the pathophysiology of Alzheimer's disease.Notably,impaired cholesterol metabolism in the liver may exacerbate the development of Alzheimer's disease.In this review,we explore the underlying causes of Alzheimer's disease and elucidate the role of the liver in amyloid-beta clearance and cholesterol metabolism.Furthermore,we propose that restoring normal cholesterol metabolism in the liver could represent a promising therapeutic strategy for addressing Alzheimer's disease.
基金supported by the General Program of National Natural Science Foundation of China(Nos.81373662 and 81874475)the Capacity Building Project of Chinese and Western Medicine Clinical Collaboration on major difficult disease in 2019,the National Natural Science Foundation of China(Nos.82004383 and 81873314)and the Science and Technology Program of Guangzhou(No.202102010273).
文摘To the Editor:Osteoarthritis(OA)is one of the most common age-related diseases and is characterized by synovial inflammation and progressive degradation of cartilage.It was reported that one-third of 65-year-olds and 303 million people globally were affected by OA in 2017.[1,2]Although there is extensive research published on OA,its pathogenesis remains unclear and controversial.Cartilage degeneration is considered a key pathological factor that leads to disease progression.
